Montgomery Man Found Guilty of Selling Fentanyl Pills that Resulted in Another Man’s Death
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Montgomery Man Found Guilty of Selling Fentanyl Pills that Resulted in Another Man’s Death

Montgomery Man Found Guilty of Selling Fentanyl Pills that Resulted in Another Man’s Death

August 15, 2024
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Public Information Officer
Phone Number: 571-362-2805

Montgomery, Alabama – On August 15, 2024, a federal jury convicted 37-year-old Lawrence Coley, III, a resident of Montgomery, Alabama, on charges of distribution of a controlled substance resulting in death and possession of fentanyl with intent to distribute the illegal drug, announced United States Attorney Jonathan S. Ross.

According to court records and evidence presented during Coley’s trial, on August 26, 2022, law enforcement received a report of an unresponsive person inside a vehicle at a Montgomery residence. Officers arrived at the location and found a truck in the driveway. The truck’s ignition was on, and doors were locked. Inside they found a lifeless man with no visible signs of trauma or injury that would have caused his death. A medical examiner concluded that the victim died due to the toxic effects of fentanyl, a potent synthetic opioid. The jury heard expert testimony stating that the quantity of fentanyl found in the victim’s blood was four to five times the lethal dose.

An investigation into how the victim obtained the fentanyl revealed that, for over a year, Coley had been supplying the victim with illegal narcotics. These transactions occurred almost daily and sometimes even multiple times a day. The jury also heard testimony verifying that the victim purchased narcotics from Coley on the very morning of his death. Investigators obtained a search warrant for Coley’s residence and found 70 blue pills with “M” marked on one side, and “30” on the opposite side. The pills’ color and markings made them look like pharmaceutical oxycodone tablets. However, lab tests determined the pills were counterfeit and contained fentanyl instead of oxycodone. When officers arrested Coley during a traffic stop, they found him in possession of five additional counterfeit fentanyl pills.

In finding Coley guilty, the jury determined that the fentanyl sold by Coley to the victim caused his death and that Coley intended to distribute the fentanyl pills in his possession.“Counterfeit pills containing fentanyl have become commonplace in Alabama and throughout the United States,” said United States Attorney Ross. “Everyone should assume that any pill that does not come from a doctor or pharmacy may contain a fatal dose of fentanyl or another deadly drug. My office is committed to holding accountable individuals who sell these dangerous pills.” 

“The top priority of the Drug Enforcement Administration is to hold accountable those individuals and drug trafficking organizations who poison our communities with deadly drugs like fentanyl,” said DEA Special Agent in Charge Steven Hofer. “Today’s conviction is a step forward in our mission to build teams that save lives and make communities safer. While we celebrate this victory, we must remember the tragic death caused by the callous disregard for human life exhibited by this individual. The conviction sends a clear message: those who choose profit over people will be held accountable.”

Following this conviction, Coley faces a sentence of 20 years to life in federal prison. A sentencing hearing for Coley will be scheduled in the coming months. At that hearing, a federal district court judge will determine Coley’s sentence after considering the United States Sentencing Guidelines and other statutory factors.

The Drug Enforcement Administration and the Montgomery Police Department investigated this case, with assistance from the Alabama Department of Forensic Sciences and the Alabama Attorney General’s Office. Assistant United States Attorneys Brandon W. Bates and Christopher P. Moore are prosecuting the case.

Download Press Release
###
Fentanyl
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Steven L. Hofer Special Agent in Charge - New Orleans
@DEANewOrleans
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster